UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.20 +0.20 (+0.25%) GOLD FUTURES
2,316.20 +5.20 (+0.23%) DOW
38,267.59 +364.30 (+0.96%) Bitcoin GBP
47,355.49 +32.73 (+0.07%)
Roche Holding AG (RHHVF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 02:22PM EDT. Market open.
| Previous close | 236.00 |
| Open | 239.17 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 234.20 - 240.24 |
| 52-week range | 234.20 - 323.78 |
| Volume | |
| Avg. volume | 10,539 |
| Market cap | 193.578B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 15.01 |
| EPS (TTM) | 15.72 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 10.86 (4.60%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
ZacksRoche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
© 2024 Yahoo. All rights reserved.